Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Study Of Adjuvant Hormonal Therapy With And Without Docetaxel And Estramustine In Patients With Advanced Prostate Cancer Or With A High Risk Of Relapse

NCT00055731 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT00055731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00055731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Study Of Adjuvant Hormonal Therapy With And Without Docetaxel And Estramustine In Patients With Advanced Prostate Cancer Or With A High Risk Of Relapse
Lead sponsor
UNICANCER
Phase
Phase 3
Overall status
Completed
Start date
November 14, 2002
Completion date
December 31, 2022
Enrollment
413 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer